Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children.

Authors:
Bucciol G; COVID Human Genetic Effort; Meyts I.

Journal:
J Allergy Clin Immunol

Publication Year: 2023

DOI:
10.1016/j.jaci.2023.02.003

PMCID:
PMC9951110

PMID:
36841740

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Allergy Clin Immunol

Abbreviation: J Allergy Clin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency.
Jauch AJ; Bignucolo O; Seki S and 34 more (2023) - Transparency Score: 3/6
Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacilli…
Ananthula S; Krishnaveni Sivakumar K; Cardone M and 6 more (2023) - Transparency Score: 3/6
Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inf…
LeSuer WE; Kienzl M; Ochkur SI and 7 more (2023) - Transparency Score: 4/6
Phospholipid remodeling and its derivatives are associated with COVID-19 severity.
Wei J; Liu X; Xiao W and 13 more (2023) - Transparency Score: 3/6
Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory disea…
Berner J; van de Wetering C; Jimenez Heredia R and 10 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure of potential conflict of interest: The authors declare that they have no conflicts of interest relevant to this manuscript."

Evidence found in paper:

"Supported by the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN-RITA). I.M. is a senior clinical investigator at the Research Foundation–Flanders (FWO 10.13039/501100011878Vlaanderen) and is supported by a 10.13039/501100004040Katholieke Universiteit Leuven C1 (grant C16/18/007), the 10.13039/501100000780European Commission under Horizon Europe project UNDINE GA 10127100, the Research Foundation–10.13039/501100011878Flanders (grants G0C8517N, G0B5120N, and G0E8420N), a 10.13039/501100000781European Research Council Starting Grant, and the 10.13039/100001245Jeffrey Modell Foundation. H.C.S. and L.D.N. (listed under the COVID-Human Genetic Effort Consortium Consortium) are supported by the Division of Intramural Research of the 10.13039/100000060National Institute of Allergy and Infectious Diseases, NIH. J.L.C. is supported by the 10.13039/100000002National Institutes of Health (grants R01AI088364, R01AI163029, and UL1TR001866), 10.13039/100001621Fisher Center for Alzheimer’s Research Foundation, 10.13039/100005162Meyer Foundation, 10.13039/100007457JPB Foundation, 10.13039/501100001665French National Research Agency (grants ANR-10-IAHU-01, ANR-10-LABX-62-IBEID, ANR-20-CE93-003, ANR-20-CO11-0001), French Foundation for Medical Research (grant EQU201903007798), ANRS-COV05, the European Union’s 10.13039/501100007601Horizon 2020 Research and Innovation Program (grant 824110; EASI-Genomics), HORIZON-HLTH-2021-DISEASE-04 Program (grant 01057100; UNDINE), the ANR-RHU COVIFERON Program (grant ANR-21-RHUS-08), the Square Foundation, Grandir-Fonds de solidarité pour l’enfance, the 10.13039/100012019Fondation du Souffle, the SCOR Corporate Foundation for Science, and the French 10.13039/501100002385Ministry of Higher Education, Research, and Innovation (grant MESRI-COVID-19)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025